Brooks Labs signed an MoU with Steriscience Specialties & BSL. It reduces Brooks' BSL stake to 32.67% for ₹106.33 Cr cash. The agreement protects Brooks' remaining investment value and defines future capital/dilution terms, plus releases its guarantees.